TD Asset Management’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $483K | Hold |
|
|||||
|
2025
Q1 | $504K | Buy |
|
|||||
|
2024
Q4 | $739K | Sell |
|
|||||
|
2024
Q3 | $932K | Buy |
|
|||||
|
2024
Q2 | $593K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $475K | Hold |
|
|||||
|
2022
Q3 | $558K | Hold |
|
|||||
|
2022
Q2 | $548K | Sell |
|
|||||
|
2022
Q1 | $884K | Sell |
|
|||||
|
2021
Q4 | $2.6M | Buy |
|
|||||
|
2021
Q3 | $2.07M | Hold |
|
|||||
|
2021
Q2 | $2.12M | Buy |
|
|||||
|
2021
Q1 | $2.13M | Buy |
|
|||||
|
2020
Q4 | $1.25M | Hold |
|
|||||
|
2020
Q3 | $1.32M | Buy |
|